The company’s exhibitions will be focused in the areas of its pipeline, proprietary capsid engineering, and manufacturing. Thousand Oaks, Calif.-based Capsida Biotherapeutics (Capsida) has announced ...
It was the summer of 2020. Pandemic aside, things were going well for Tuyen Ong, M.D. The physician and biotech entrepreneur was heading up the opthamology franchise unit of Biogen following its ...
On Nov. 21, 2016, the American Society of Gene & Cell Therapy (ASGCT) released Therapeutic Gene Editing: an ASGCT White Paper, intended to provide policy-makers, patient advocates, and the interested ...
- FORCE Delivers to CNS in Non-Human Primates -- FORCE Achieves Robust Reduction of Toxic Nuclear DMPK RNA and Foci in Brain of a DM1 Disease Model - The FORCE platform was designed to overcome the ...
HANGZHOU, China, May 14, 2025--(BUSINESS WIRE)--Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable genome editing technology ...
More than 10,000 known rare diseases affect over 30 million people in the United States. However, treatment options have been restricted due to small patient populations and limited commercial ...
SAIL-0804 shows rapid and deep B cell depletion along with repopulation by mostly immature phenotypes in preclinical models, supporting its advancement into IND-enabling studies "SAIL-0804 represents ...
SAN DIEGO--(BUSINESS WIRE)--Cytonus Therapeutics Inc., a biotechnology company developing new platforms for delivering biologics, announced today that it will be presenting preclinical data for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results